• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors.

作者信息

Guo Zhuyan, Orth Peter, Wong Shing-Chun, Lavey Brian J, Shih Neng-Yang, Niu Xiaoda, Lundell Daniel J, Madison Vincent, Kozlowski Joseph A

机构信息

Department of Chemistry, Schering-Plough Research Institute, Kenilworth, NJ 07033-0539, USA.

出版信息

Bioorg Med Chem Lett. 2009 Jan 1;19(1):54-7. doi: 10.1016/j.bmcl.2008.11.034. Epub 2008 Nov 14.

DOI:10.1016/j.bmcl.2008.11.034
PMID:19054672
Abstract

We have discovered nanomolar inhibitors of TNF-alpha convertase (TACE) comprised of a novel spirocyclic scaffold and either a carboxylate or hydroxamate zinc binding moiety. X-ray crystal structures and computer models of selected compounds binding to TACE explain the observed SAR. We report the first TACE X-ray crystal structure for an inhibitor with a carboxylate zinc ligand.

摘要

相似文献

1
Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors.
Bioorg Med Chem Lett. 2009 Jan 1;19(1):54-7. doi: 10.1016/j.bmcl.2008.11.034. Epub 2008 Nov 14.
2
Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).乙内酰脲、三唑酮和咪唑酮作为肿瘤坏死因子-α转化酶（TACE）的选择性非异羟肟酸酯抑制剂。
Bioorg Med Chem Lett. 2007 May 15;17(10):2769-74. doi: 10.1016/j.bmcl.2007.02.076. Epub 2007 Mar 3.
3
A molecular modeling analysis of novel non-hydroxamate inhibitors of TACE.肿瘤坏死因子-α转换酶新型非异羟肟酸抑制剂的分子模拟分析
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1408-12. doi: 10.1016/j.bmcl.2006.11.082. Epub 2006 Dec 3.
4
Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors: Part I--discovery of two binding modes.新型异羟肟酸酯作为高效肿瘤坏死因子-α转化酶抑制剂的发现：第一部分——两种结合模式的发现。
J Med Chem. 2008 Feb 28;51(4):725-36. doi: 10.1021/jm070376o. Epub 2008 Feb 5.
5
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.新型基于酒石酸盐的 TNF-α转化酶（TACE）抑制剂的发现。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):1189-93. doi: 10.1016/j.bmcl.2009.12.004. Epub 2009 Dec 5.
6
Discovery and SAR of hydantoin TACE inhibitors.脒基嘧啶酮 TACE 抑制剂的发现和 SAR 研究。
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1877-80. doi: 10.1016/j.bmcl.2010.01.148. Epub 2010 Feb 4.
7
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors.发现β-苯甲酰胺基异羟肟酸作为强效、选择性且口服生物可利用的肿瘤坏死因子-α转换酶抑制剂。
Bioorg Med Chem Lett. 2008 Jan 1;18(1):241-6. doi: 10.1016/j.bmcl.2007.10.093. Epub 2007 Oct 30.
8
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).α，β-环-β-苯甲酰胺异羟肟酸：用于发现肿瘤坏死因子-α转化酶（TACE）强效、选择性、口服生物可利用抑制剂的新型氧杂螺[4.4]壬烷模板。
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1288-92. doi: 10.1016/j.bmcl.2008.01.030. Epub 2008 Jan 11.
9
Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).肿瘤坏死因子-α转化酶（TACE）低纳摩尔非羟肟酸抑制剂的发现。
Bioorg Med Chem Lett. 2007 Jan 1;17(1):266-71. doi: 10.1016/j.bmcl.2006.09.048. Epub 2006 Oct 5.
10
Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.基于结构的TACE选择性抑制剂设计：对S1'-S3'口袋的操控
Bioorg Med Chem. 2007 Sep 15;15(18):6170-81. doi: 10.1016/j.bmc.2007.06.031. Epub 2007 Jun 20.

引用本文的文献

1
Discovery of FLF-15 as a novel selective inhibitor of ADAM17 to prevent hepatocellular carcinoma metastasis.发现FLF-15作为一种新型的ADAM17选择性抑制剂可预防肝细胞癌转移。
Mol Divers. 2025 Jun 26. doi: 10.1007/s11030-025-11275-7.
2
Potential Utilization of Phenolic Acid Compounds as Anti-Inflammatory Agents through TNF-α Convertase Inhibition Mechanisms: A Network Pharmacology, Docking, and Molecular Dynamics Approach.通过肿瘤坏死因子-α转化酶抑制机制将酚酸化合物用作抗炎剂的潜在用途：网络药理学、对接和分子动力学方法
ACS Omega. 2023 Nov 29;8(49):46851-46868. doi: 10.1021/acsomega.3c06450. eCollection 2023 Dec 12.
3
In Silico and Experimental ADAM17 Kinetic Modeling as Basis for Future Screening System for Modulators.
基于 ADAM17 的计算机模拟和实验动力学建模作为未来调节剂筛选系统的基础。
Int J Mol Sci. 2022 Jan 25;23(3):1368. doi: 10.3390/ijms23031368.
4
Vitamin D3 Prevents the Deleterious Effects of Testicular Torsion on Testis by Targeting miRNA-145 and ADAM17: In Silico and In Vivo Study.维生素D3通过靶向miRNA - 145和ADAM17预防睾丸扭转对睾丸的有害影响：计算机模拟和体内研究
Pharmaceuticals (Basel). 2021 Nov 25;14(12):1222. doi: 10.3390/ph14121222.
5
Simultaneous detection of multiple proteases using a non-array nanopore platform.利用非阵列纳米孔平台同时检测多种蛋白酶。
Nanoscale. 2021 Aug 28;13(32):13658-13664. doi: 10.1039/d1nr04085e. Epub 2021 Aug 3.
6
Targeting Metalloenzymes for Therapeutic Intervention.靶向金属酶治疗干预。
Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7.